176 related articles for article (PubMed ID: 16433706)
1. Fenofibrate and cardiovascular risk: a synopsis and commentary on (FIELD).
Bailey CJ
Diabet Med; 2006 Feb; 23(2):109-12. PubMed ID: 16433706
[No Abstract] [Full Text] [Related]
2. FIELD study.
Rees A
Diabet Med; 2006 Jul; 23 Suppl 3():6-12. PubMed ID: 16805876
[No Abstract] [Full Text] [Related]
3. Fenofibrate therapy and cardiovascular protection in diabetes: recommendations after FIELD.
Vergès B
Curr Opin Lipidol; 2006 Dec; 17(6):653-8. PubMed ID: 17095910
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid.
Cardiovasc J Afr; 2008; 19(3):171-2. PubMed ID: 18568186
[No Abstract] [Full Text] [Related]
5. [Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].
Båvenholm P; Attvall S; Nilsson PM
Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2462-6. PubMed ID: 17002161
[No Abstract] [Full Text] [Related]
6. [PPAR agonists do not come up to expectations. Hope about the preventive effect in type 2 diabetes has come to nought].
Olsson AG
Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2454-5. PubMed ID: 17002160
[No Abstract] [Full Text] [Related]
7. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate.
Sacks FM
Am J Cardiol; 2008 Dec; 102(12A):34L-40L. PubMed ID: 19084088
[TBL] [Abstract][Full Text] [Related]
8. ACCORD LIPID study results strengthen guideline approach of adding fenofibrate to therapy of dyslipidaemic type 2 diabetic patients.
Aalbers J
Cardiovasc J Afr; 2010; 21(2):118-9. PubMed ID: 20532440
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
Bajaj M; Jialal I
Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
[No Abstract] [Full Text] [Related]
10. Reducing ocular damage in type 2 diabetes: the FIELD study shows fenofibrate benefits.
Cardiovasc J Afr; 2007; 18(6):400. PubMed ID: 18092120
[No Abstract] [Full Text] [Related]
11. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
Steiner G
Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
[TBL] [Abstract][Full Text] [Related]
12. FIELDS of dreams, fields of tears: a perspective on the fibrate trials.
Wierzbicki AS
Int J Clin Pract; 2006 Apr; 60(4):442-9. PubMed ID: 16620358
[TBL] [Abstract][Full Text] [Related]
13. Clinical insights from the Fenofibrate Intervention and Event Lowering in Diabetes study: a community practice perspective.
Toth PP
Int J Clin Pract; 2009 Jun; 63(6):903-11. PubMed ID: 19490201
[TBL] [Abstract][Full Text] [Related]
14. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
Sacks FM
Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
[No Abstract] [Full Text] [Related]
15. Should we dismiss fibrates for the treatment of diabetic dyslipidaemia?
Taskinen MR
Nutr Metab Cardiovasc Dis; 2006 Dec; 16(8):509-12. PubMed ID: 17071064
[No Abstract] [Full Text] [Related]
16. Combination statin-fibrate therapy: safety aspects.
Franssen R; Vergeer M; Stroes ES; Kastelein JJ
Diabetes Obes Metab; 2009 Feb; 11(2):89-94. PubMed ID: 18518891
[TBL] [Abstract][Full Text] [Related]
17. [The FIELD study presented and published. Unconvincing results of fenofibrates in diabetic patients].
Widimský J
Vnitr Lek; 2006 Jan; 52(1):80-4. PubMed ID: 16526203
[TBL] [Abstract][Full Text] [Related]
18. Therapy and clinical trials.
Usman M; Peter R
Curr Opin Lipidol; 2006 Oct; 17(5):612-4. PubMed ID: 16960511
[No Abstract] [Full Text] [Related]
19. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.
Steinmetz A
Diabetes Metab Res Rev; 2008; 24(4):286-93. PubMed ID: 18273835
[TBL] [Abstract][Full Text] [Related]
20. [Milestone in the treatment of diabetic dyslipidemia: the DAIS Study].
Forster T
Orv Hetil; 2001 Jul; 142(29):1588-9. PubMed ID: 11494751
[No Abstract] [Full Text] [Related]
[Next] [New Search]
